Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Cytochrome P450 enzymes, particularly CYP2E1, play critical roles in xenobiotic metabolism.
• Understanding CYP2E1's catalytic activities and toxicological implications requires suitable experimental models.
• The PC-12 cell line is a commonly used mammalian model for neuronal studies but lacks significant endogenous CYP2E1 expression.

Purpose of the Study:

• To establish a stable mammalian cell line, PC-12, expressing functional human cytochrome CYP2E1.
• To characterize the metabolic capabilities and catalytic competence of the expressed CYP2E1 in the engineered cell line.
• To utilize this recombinant cell line for investigating the cytotoxic effects of CYP2E1-metabolized substrates.

Main Methods:

• Construction of an expression plasmid containing human CYP2E1 cDNA under the Rous sarcoma virus (RSV) promoter.
• Co-transfection of the CYP2E1 expression plasmid and the RSVneo plasmid into PC-12 cells.
• Selection of transfected clones using G418 and screening for CYP2E1 expression via chlorzoxazone 6-hydroxylation.
• Confirmation of CYP2E1 expression using Western blot analysis and measurement of specific monooxygenase activities.
• Assessment of acetaminophen metabolism and associated cytotoxicity (lactate dehydrogenase release).

Main Results:

• Stable expression of human CYP2E1 was achieved in the PC-12 cell line, designated clone DB-7.
• The DB-7 cells exhibited significant CYP2E1-specific monooxygenase activities, including chlorzoxazone 6-hydroxylation, n-butanol oxidation, and dimethylnitrosamine N-demethylation.
• These activities were localized in microsomes and sensitive to known P450 inhibitors (carbon monoxide, diethyldithiocarbamate).
• Although enzyme activity levels were lower than in human liver microsomes, the catalytic competence of expressed CYP2E1 was comparable.
• Metabolism of acetaminophen by DB-7 cells led to observable cytotoxicity, indicated by lactate dehydrogenase release.

Conclusions:

• The development of the DB-7 cell line provides a robust model for studying human CYP2E1.
• This recombinant cell line enables detailed investigation of CYP2E1's catalytic functions and substrate-specific toxicological effects.
• The DB-7 system serves as a valuable tool for drug metabolism and toxicology research, particularly concerning compounds metabolized by CYP2E1.